Market Access Head at Abbott

Lima, Callao Region, Peru

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Bachelor's degree with 8 years of experience
Fluent English and Spanish (spoken and written)

Responsibilities

Build and implement the Market access strategy for EPD’s existing and future portfolio
Lead the Institutional Business for Biosimilars, Oncology, and vaccination products in Peru
Build and execute the listing strategy in the Institutional Private segment
Build and execute the reimbursement strategy in public segment
Secure reimbursement for products through timely preparation of submissions, effective understanding of local processes, and networking with key stakeholders
Organize and implement accurate customer segmentation for Peru
Work as the focal point of contact between the regional team and the affiliate
Lead pricing initiatives across the portfolio and define local price strategy for Biosimilars and Oncology Products
Accelerate Tender Management Excellence in the Country
Early engagement with relevant stakeholders for Biosimilars at C-suite level and at Government
Build or adapt Value Dossier at local level and develop or implement HEOR initiatives

Skills

Market Access

Biosimilars

Oncology

Key Account Management

Reimbursement Strategy

Pricing Strategy

Stakeholder Management

Customer Segmentation

Institutional Business

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters

1888Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.

Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.

Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.

Abbott's microfluidic devices streamline diagnostic processes efficiently.

Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.

Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.

Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI

Try Jobo Free